Phytochemicals suppress nuclear factor-κB signaling: Impact on health span and the aging process

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 15, Issue 1, 2012, Pages 23-28

  Salminen, Antero ^a,b   Kauppinen, Anu ^a   Kaarniranta, Kai ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Aging; AMP activated protein kinase; Health span; Nuclear factor B; Nuclear factor erythroid 2 related factor 2; Phytochemicals

Indexed keywords

ARTEMISININ; BERBERINE; CELASTROL; CURCUMIN; EPIGALLOCATECHIN GALLATE; FLAVONOID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KAHWEOL; LYCOPENE; METFORMIN; PARTHENOLIDE; PLANT MEDICINAL PRODUCT; RESVERATROL; STILBENE; TRANSCRIPTION FACTOR NF E2; TUMOR NECROSIS FACTOR ALPHA; XANTHOPHYLL;

AGING; ANTIINFLAMMATORY ACTIVITY; ATHEROSCLEROSIS; CACHEXIA; CANCER GROWTH; CARDIOVASCULAR DISEASE; DEGENERATIVE DISEASE; HUMAN; INTRACELLULAR SIGNALING; MOLECULARLY TARGETED THERAPY; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXIDATIVE STRESS; REVIEW; SIGNAL TRANSDUCTION;

AGING; AMP-ACTIVATED PROTEIN KINASES; ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; HUMANS; INFLAMMATION; NEOPLASMS; NF-E2-RELATED FACTOR 2; NF-KAPPA B; PHYTOTHERAPY; PLANT EXTRACTS; SIGNAL TRANSDUCTION;

EID: 84857035526     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0b013e32834d3ae7     Document Type: Review

References (43)

1. Graziose] R, Lila MA, Raskin I. Merging traditional Chinese medicine with modern drug discovery technologies to find novel drugs and functional foods. Curr Drug Discov Technol 2010; 7: 2-12.
2. Salminen A, Lehtonen M, Suuronen T, et al. Terpenoids: natural inhibitors of NF-κB signaling with anti-inflammatory and anticancer potential. Cell Mol Life Sci 2008; 65: 2979-2999.
3. Franceschi C, Bonafe M, Valensin S, et al. Inflamm-aging: an evolutionary perspective of immunosenescence. Ann N Y Acad Sci 2000; 908: 244-254.
4. Cevenini E, Caruso C, Candore G, et al. Age-related inflammation: the contribution of different organs, tissues and systems. How to face it for therapeutic approaches. Curr Pharm Des 2010; 16: 609-618.
5. Singh T, Newman AB. Inflammatory markers in population studies of aging. Ageing Res Rev 2011; 10: 319-329.
6. Ungvari Z, Kaley G, de Gabo R, et al. Mechanisms of vascular aging: new perspectives. J Geront A Biol Sci Med Sci 2010; 65: 1028-1041.
7. Salminen A, Kaarniranta K. Genetics vs. entropy: longevity factors suppress the NF-κB-driven entropic aging process. Ageing Res Rev 2010; 9: 298-314.
8. Hayden MS, Ghosh S. NF-κB in immunobiology. Cell Res 2011; 21: 223-244.
9. Adler AS, Sinha S, Kawahara TL, et al. Motif module map reveals enforcement of aging by continual NF-κB activity. Genes Dev 2007; 21: 3244-3257.
10. Salminen A, Hyttinen JM, Kaarniranta K. AMP-activated protein kinase inhibits NF-κB signaling and inflammation: impact on healthspan and lifespan. J Mol Med (Berl) 2011; 89: 667-676.
11. Salminen A, Kauppinen A, Suuronen T, Kaarniranta K. SIRT1 longevity factor suppresses NF-κB-driven immune responses: regulation of aging via NF-κB acetylation? Bioessays 2008; 30: 939-942.
12. Ruderman NB, Xu XJ, Nelson L, et al. AMPK and SIRT1: a long-standing partnership? Am J Physiol Endocrinol Metab 2010; 298: E751-E760.
13. De Magalhaes JP, Curado J, Church GM. Meta-analysis of age-related gene expression profiles identifies common signatures of aging. Bioinformatics 2009; 25: 875-881.
14. Coppe JP, Desprez PY, Krtolica A, Campisi J. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol 2010; 5: 99-118.
15. Freund A, Orjalo AV, Desprez PY, Campisi J. Inflammatory networks during cellular senescence: causes and consequences. Trends Mol Med 2010; 16: 238-246.
16. Freund A, Patil CK, Campisi J. p38MAPK is a novel DNA damage responseindependent regulator of the senescence-associated secretory phenotype. EMBO J 2011; 30: 1536-1548.
17. Rovillain E, Mansfield L, Caetano C, et al. Activation of nuclear factor-kappa B signaling promotes cellular senescence. Oncogene 2011; 30: 2356-2366.
18. Obrenovich ME, Nair NG, Beyaz A, et al. The role of polyphenolic antioxidants in health, disease, and aging. Rejuvenation Res 2010; 13: 631-643.
19. Baker RG, Hayden MS, Ghosh S. NF-κB, inflammation, and metabolic disease. Cell Metab 2011; 13: 11-22.
20. Brigelius-Flohe R, Flohe L. Basic principles and emerging concepts in the redox control of transcription factors. Antioxid Redox Signal 2011; 15: 2335-2381.
21. Surh YJ, Kundu JK, Na HK. Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals. Planta Med 2008; 74: 1526-1539.
22. Singh S, Vrishni S, Singh BK, et al. Nrf2-ARE stress response mechanism: a control point in oxidative stress-mediated dysfunctions and chronic inflammatory diseases. Free Radic Res 2010; 44: 1267-1288.
23. Kim JE, You DJ, Lee C, et al. Suppression of NF-κB signaling by KEAP1 regulation of IKKb activity through autophagic degradation and inhibition of phosphorylation. Cell Signal 2010; 22: 1645-1654.
24. Halford NG, Hey SJ. Snf-related protein kinases (snRKs) act within an intricate network that links metabolic and stress signalling in plants. Biochem J 2009; 419: 247-259.
25. Hardie DG. Sensing of energy and nutrients by AMP-activated protein kinase. Am J Clin Nutr 2011; 93: 891S-896S.
26. Varela L, Vazquez MJ, Cordido F, et al. Ghrelin and lipid metabolism: key partners in energy balance. J Mol Endocrinol 2011; 46: R43-R63.
27. Hwang JT, Kwon DY, Yoon SH. AMP-activated protein kinase: a potential target for the diseases prevention by natural polyphenols. N Biotechnol 2009; 26: 17-22.
28. Jeong HW, Hsu KC, Lee JW, et al. Berberine suppresses proinflammatory responses through AMPK activation in macrophages. Am J Physiol Endocrinol Metab 2009; 296: E955-E964.
29. Chung S, Yao H, Caito S, et al. Regulation of SIRT1 in cellular functions: role of polyphenols. Arch Biochem Biophys 2010; 501: 79-90.
30. Gonzalez R, Ballester I, Lopez-Posadas R, et al. Effects of flavonoids and other polyphenols on inflammation. Crit Rev Food Sci Nutr 2011; 51: 331-362.
31. Gupta SC, Sundaram C, Reuter S, Aggarwal BB. Inhibiting NF-κB activation by small molecules as a therapeutic strategy. Biochim Biophys Acta 2010; 775-787.
32. Salminen A, Lehtonen M, Paimela T, Kaarniranta K. Celastrol: molecular targets of Thunder God Vine. Biochem Biophys Res Commun 2010; 394: 439-442.
33. Prasad S, Ravindran J, Aggarwal BB. NF-κB and cancer: how intimate is this relationship. Mol Cell Biochem 2010; 336: 25-37.
34. Aravindaram K, Yang NS. Anti-inflammatory plant natural products for cancer therapy. Planta Med 2010; 76: 1103-1117.
35. Omar EA, Kam A, Alqahtani A, et al. Herbal medicines and nutraceuticals for diabetic vascular complications: mechanisms of action and bioactive phytochemicals. Curr Pharm Des 2010; 16: 3776-3807.
36. Hirai S, Takahashi N, Goto T, et al. Functional food targeting the regulation of obesity-induced inflammatory responses and pathologies. Mediators Inflamm 2010; 2010: 367838.
37. Olefsky JM, Glass CK. Macrophages, inflammation, and insulin resistance. Annu Rev Physiol 2010; 72: 219-246.
38. Sell H, Eckel J. Adipose tissue inflammation: novel insight into the role of macrophages and lymphocytes. Curr Opin Clin Nutr Metab Care 2010; 13: 366-370.
39. Salminen A, Kaarniranta K. Glycolysis links p53 function with NF-κB signaling: impact on cancer and aging process. J Cell Physiol 2010; 224: 1-6.
40. Gareus R, Kotsaki E, Xanthoulea S, et al. Endothelial cell-specific NF-κB inhibition protects mice from atherosclerosis. Cell Metab 2008; 8: 372-383.
41. Gupta SC, Kim JH, Kannappan R, et al. Role of nuclear factor-κB-mediated inflammatory pathways in cancer-related symptoms and their regulation by nutritional agents. Exp Biol Med 2011; 236: 658-671.
42. Shadfar S, Couch ME, McKinney KA, et al. Oral resveratrol therapy inhibits cancer-induced skeletal muscle and cardiac atrophy in vivo. Nutr Cancer 2011; 63: 749-762.
43. Perez-Martinez P, Garcia-Rios A, Delgado-Lista J, et al. Mediterranean diet rich in olive oil and obesity, metabolic syndrome and diabetes mellitus. Curr Pharm Des 2011; 17: 769-777.